U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT06931275) titled 'Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes' on Sept. 09, 2024.
Brief Summary: The overall goal of the study is to create a standardized, stakeholder-informed system within EMRs, that will enable an equitable and regular prescription and documentation of advanced diabetes technologies. This will reduce racial disparities and generate an understanding of the reasons behind prescription decisions.
The study will highlight the development and implementation an EMR-based Best Practice Advisory (BPA).
The study will answer whether the EMR-based BPA can effectively reduce disparities....